Renvela
Product Images NDC 17856-0130

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Renvela (NDC 17856-0130). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Atlantic Biologicals Corps, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl178560130)

Renvela® is a medication in the form of a 800mg film-coated tablet containing sevelamer carbonate. The expiration date for one tablet is March 5th, 2017. The manufacturer of this medication is Genzyme, and it was packaged by UDose in Miami, FL. The lot number for the medication is XO0OOXKX and the distributor is Atlantic Biologicals.*

FDA Label Image

Figure 1 (Renvela 01)

This appears to be a chemical formula with the symbols NH2, NH, NH, and OH. It is likely related to molecular or organic chemistry. However, without further context or information, it is not possible to determine the specific meaning or application of this text.*

FDA Label Image

Figure 2 (Renvela 02)

FDA Label Image

Figure 3 (Renvela 03)

This is a graph showing the reduction in serum phosphorus as a percentage of patients for active control and sevelamer hydrochloride with reduction of X. The graph indicates a marked improvement in serum phosphorus in patients treated with sevelamer hydrochloride. The reduction in serum phosphorus is measured in mg/dL.*

FDA Label Image

Figure 4 (Renvela 04)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.